arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

PRO DEX INC

PDEX
$65.69 ▲ +0.41 (+0.63%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
16 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
64
Health
Fair
Bullish
auto_awesome

Analytical Summary

PRO DEX INC shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $216.0M
Dividend Yield
Revenue Growth 23.7%
Op. Margin 16.1%
ROIC 15.3%
FCF / Share $-0.51
Trailing P/E 24.1x
Price / Book 5.9x
FCF Yield
Debt / Equity 0.42
info Valuation on last close. End-of-day price, Aug 7, 2026.

16-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$66.59M
↑ +23.7%
Net Income Profit after all expenses
$8.98M
↑ +322.1%
Operating Margin Operating profit as % of sales
16.1%
↑ +20.5% 69th
FCF / Share Free cash flow per share
$-0.51
↓ -128.9%
Long-Term Debt Long-term obligations
$15.43M
↑ +29.1%
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
53
Returns
90
Financial Health
70
Cash Quality
17

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 64 quarters